Gorillacillin and the Tragedy of the Commons
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
In the wake of my recent New York Times op-ed, and other writing about patient out-of-pocket costs, I was interviewed by Tammy Worth, a writer at Renal and Urology News. She did a great job of exploring this controversial topic. Here is a sneak peek at her article, followed by a link to the full…
A very disturbing new study was just published, in which physicians viewed a video of a patient with back pain asking for OxyContin. Twenty percent of docs said they would prescribe that med under that circumstance: …Too often, doctors prescribe potentially dangerous medications to patients who shouldn’t be getting them, and what they prescribe is…
My visit to this well-intentioned dermatologist illustrates one of the flaws of this idea of consumer empowerment.
![]()
Brian Zikmund-Fisher took the lead on a study published this week in which we found evidence that when people face tough decisions, it helps for them to break the decision into smaller pieces, and take it one step at a time. Here is a link to some media coverage in India.
As if being diagnosed with breast cancer wasn’t bad enough, many women with this diagnosis face complicated decisions about what kind of medicine or chemotherapy to take, if any, to reduce their chance of cancer recurrence. As I discussed in a recent post, the mathematics of such decisions can be hard to comprehend for many patients. …
Under the Big Beautiful Bill, the federal government is making steep cuts to Medicaid funding. Those cuts could increase the price you pay for medical care. Here’s why when the government cuts Medicaid funding, we all pay the price. Read more here